"10 years of PBMI data show that, yes, there are higher tiers and copayments for specialty drugs, but cost sharing for these stratospherically expensive drugs has actually dropped, probably because their introduction and subsequent cost inflation has occurred so fast that insurance plans can't keep up with it. Even more surprising, value-based pharmacy benefit design was actually being used less in 2014 than in previous years. More than half (53 percent) of the respondents reported using none of the evidence-based tactics listed in the survey, compared with 43 percent in 2011.... These rather surprising trends away from value-based benefit design probably don't mean that employers are slacking off on encouraging wellness to cut insurance costs. Instead, employers may be finding more effective ways of influencing employees' health choices."  MORE >>